Search | La Lingua Nostra

added article Other

2026-04-01 10:27:47 -

Global Nivolumab Market Forecast 2026–2034: Expanding at 7.3% CAGR to Hit USD14.76B

According to a new report from Intel Market Research, the global Nivolumab market was valued at USD 7.85 billion in 2025 and is projected to reach USD 14.76 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026-2034). This growth is driven by the increasing prevalence of cancer worldwide, expanding applications of immunotherapy, and growing adoption of PD-1 inhibitors in...

0 Comments 0 Shares 3 Views 0 Reviews